Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02538926
Title Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of Washington
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field